Leukocyte arylsulfatase a activity in patients with alcohol-related cirrhosis

被引:7
作者
Alvarez-Leal, M
Contreras-Hernández, D
Chávez, A
Diaz-Contreras, JA
Careaga-Olivares, J
Zúñiga-Charles, MA
Reynoso, MC
Hernandez-Téllez, A
机构
[1] IMSS, Ctr Invest Biomed Noreste, Monterrey 64720, NL, Mexico
[2] IMSS, Unidad Med Familiar 2, Monterrey, NL, Mexico
[3] IMSS, Hosp 25, Mexico City, DF, Mexico
[4] Salud Jalisco, Mexico City, DF, Mexico
[5] IMSS, Genet Ctr Invest Biomed Occidente, Guadalajara, Jalisco, Mexico
关键词
D O I
10.1002/ajhb.1052
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Arylsulfatase (ASA) enzyme deficiency is associated with metachromatic leukodystrophy (MLD), which is a hereditary myelin metabolic disease. It has been proposed that in alcoholic subjects with abnormal ASA, the accumulation of sulfatides may lead to demyelinization and generalized cerebral atrophy. ASA may be diminished in subjects with alcoholic cirrhosis having encephalopathic manifestations. This idea has not been previously proposed. Leukocyte arylsulfatase A (ASA) activity was measured in 30 healthy male volunteers and 28 patients with alcohol-related cirrhosis. The patients were divided into two groups: patients with alcohol-related cirrhosis with hepatic encephalopathy history and patients with alcoholic cirrhosis without history of hepatic encephalopathy. Alcoholic cirrhotic patients with history of encephalopathy showed 58.21% (40.95 nmol/mg protein/h) less enzymatic activity than a control group (98.00 nmol/mg protein/h), whereas the group without ,history of encephalopathy showed an ASA value which was 38.2% (60.55 nmol/mg protein/h) less than the control group. The results suggest that the low ASA activity is a factor associated to the appearance of encephalopathy in patients with alcohol-related cirrhosis. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:297 / 300
页数:4
相关论文
共 16 条
[1]  
Alvarez Leal M, 1995, Rev Invest Clin, V47, P387
[2]   A PEDIGREE STUDY OF METACHROMATIC LEUKODYSTROPHY . BIOCHEMICAL IDENTIFICATION OF CARRIER STATE [J].
BASS, NH ;
WITMER, EJ ;
DREIFUSS, FE .
NEUROLOGY, 1970, 20 (01) :52-&
[3]  
BERATIS NG, 1973, J PEDIATR-US, V83, P824, DOI 10.1016/S0022-3476(73)80377-4
[4]  
CZAJA AJ, 1980, MAYO CLIN PROC, V55, P360
[5]   PROBABLE METACHROMATIC LEUKODYSTROPHY PSEUDODEFICIENCY COMPOUND HETEROZYGOTE AT THE ARYLSULFATASE-A LOCUS WITH NEUROLOGICAL AND PSYCHIATRIC SYMPTOMATOLOGY [J].
HOHENSCHUTZ, C ;
FRIEDL, W ;
SCHLOR, KH ;
WAHEED, A ;
CONZELMANN, E ;
SANDHOFF, K ;
PROPPING, P .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1988, 31 (01) :169-175
[6]   ARYLSULFATASE-A VARIANTS IN PATIENTS WITH ALCOHOLISM [J].
HULYALKAR, AR ;
NORA, R ;
MANOWITZ, P .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1984, 8 (03) :337-341
[7]  
KENICHI T, 1990, J NEUROCHEM, V55, P1585
[8]  
Kolodny E., 1995, METABOLIC MOL BASES, P2693
[9]   Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease [J].
Kril, JJ ;
Butterworth, RF .
HEPATOLOGY, 1997, 26 (04) :837-841
[10]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265